Clinical outcomes and considerations of gender-affirming care for transgender and gender-diverse pediatric and young adult patients with cancer
Pediatr Blood Cancer
.
2023 Jan;70(1):e29851.
doi: 10.1002/pbc.29851.
Epub 2022 Jul 7.
Authors
Abigail M Kempf
1
,
Zackory T Burns
2
,
Carly E Guss
3
4
,
Kate Millington
4
5
,
Sarah Pilcher
5
,
Patrick J Boyle
6
,
Brittany M Charlton
3
7
8
,
Daphne A Haas-Kogan
6
,
Kevin X Liu
6
Affiliations
1
Harvard Medical School, Boston, Massachusetts, USA.
2
Center for Biotechnology and Global Health Policy, University of California, Irvine School of Law, Irvine, California, USA.
3
Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
4
Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
5
Division of Endocrinology, Boston Children's Hospital, Boston, Massachusetts, USA.
6
Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston Children's Hospital, Boston, Massachusetts, USA.
7
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
8
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
PMID:
35713118
PMCID:
PMC9701144
DOI:
10.1002/pbc.29851
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Child
Humans
Neoplasms* / therapy
Transgender Persons*
Young Adult
Grants and funding
L40 CA264321/CA/NCI NIH HHS/United States